PERINI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.285
EU - Europa 1.065
AS - Asia 637
AF - Africa 8
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.004
Nazione #
US - Stati Uniti d'America 5.271
IT - Italia 398
CN - Cina 364
SG - Singapore 226
FI - Finlandia 166
SE - Svezia 125
DE - Germania 110
UA - Ucraina 110
FR - Francia 74
GB - Regno Unito 54
VN - Vietnam 24
CA - Canada 14
IN - India 11
DZ - Algeria 8
IE - Irlanda 8
HK - Hong Kong 7
CH - Svizzera 4
NL - Olanda 4
RU - Federazione Russa 4
BG - Bulgaria 3
BR - Brasile 2
HR - Croazia 2
JP - Giappone 2
PE - Perù 2
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.004
Città #
Woodbridge 625
Fairfield 619
Jacksonville 531
Ann Arbor 466
Houston 466
Chandler 452
Wilmington 303
Ashburn 256
Cambridge 213
Seattle 203
Princeton 166
Singapore 164
San Diego 86
Medford 84
Beijing 76
Nanjing 75
Padova 69
Helsinki 52
Roxbury 46
Des Moines 45
Boardman 37
Santa Clara 34
Rome 30
Shenyang 28
Jiaxing 25
Dong Ket 24
Nanchang 24
Hebei 21
Guangzhou 18
Florence 15
Milan 15
Norwalk 15
Tianjin 15
New York 13
Changsha 11
Jinan 11
Verona 11
Redwood City 10
Bologna 8
Dublin 8
Oran 8
Zhengzhou 8
Brescia 7
Hong Kong 7
Kharkiv 7
London 7
Borås 6
Ningbo 5
Ogden 5
Bari 4
Ottawa 4
Alatri 3
Amsterdam 3
Casier 3
Catania 3
Cavagnolo 3
Cesena 3
Frankfurt am Main 3
Haikou 3
Hangzhou 3
Hounslow 3
Indiana 3
Kunming 3
Las Vegas 3
Messina 3
Munich 3
New Bedfont 3
Reggio Calabria 3
Southend 3
Staten Island 3
Venezia 3
Wandsworth 3
Washington 3
Winnipeg 3
Atlanta 2
Augusta 2
Brasília 2
Breda Di Piave 2
Brownsville 2
Buffalo 2
Dallas 2
Fossò 2
Guiglia 2
Iesi 2
Kilburn 2
L'aquila 2
Lanzhou 2
Lima 2
Melfa 2
Modugno 2
Montreal 2
Monza 2
Napoli 2
North Charleston 2
Oggiono 2
Palmdale 2
Parma 2
Pisa 2
Prescot 2
Rimini 2
Totale 5.559
Nome #
Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). 323
Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26 156
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression 153
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus 124
Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. 121
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report. 110
Hippocampal remodelling after MDMA neurotoxicity: a single case study 109
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorder 104
Cognitive and psychiatric evaluation of 40 patients with myotonic dystrophy. 102
The metyrapone test in manic patients and healthy subjects. 100
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia 98
Life events and alopecia areata. 96
Research diagnostic criteria (RDC) mental disorder and self-reported symptoms in outpatients with complex partial seizures (CPS). 95
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder 94
Hypochondriacal fears and beliefs in DSM-III melancholia. Changes with amitriptyline. 92
The lithium loading dose method in a clinical setting. 92
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS 90
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 90
Effects of carbamazepine on pituitary-adrenal function in healthy volunteers 90
Hostility and recovery from melancholia. 88
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 87
Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants 86
Noradrenergic receptor sensitivity in obsessive compulsive disorder: II. Cortisol response to acute clonidine administration. 84
Depression and anxiety in complex partial seizures. 84
The metyrapone test in schizophrenic patients and healthy subjects. 83
Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I Growth hormone Response to Clonidine stimulation 82
Psychoimmunoendocrine aspects of panic disorder 82
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 81
Interictal Mood and Personality Disorders in complex partial epilepsy and Juvenile Myoclonic Epilepsy 80
Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats 80
Emotions and personality in complex partial seizures. 79
The metyrapone test in affective disorders and schizophrenia. 78
Late-onset OCD as presenting manifestation of semantic dementia. 77
Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. 76
Paroxetine in alopecia areata 75
Rating depression in normals and depressives: observer versus self-rating scales. 75
Evaluation of linkage signals in a subset of families with high recurrence of schizophrenia and bipolar disorder originating from Chioggia 74
Cognitive Impairment and (CTG)n expansion in myotonic dystrophy patients 74
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age 74
Aripiprazole in acute mania and long-term treatment of bipolar disorder. A critical review by an Italian Working group 73
Cognitive disorders and cerebral perfusion abnormalities in SLE 73
The metyrapone test in depressed males. 73
Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: A model for glucocorticoid neural modulation 72
Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. 72
The dexamethasone suppression and metyrapone tests in depression. 72
Recurrent major depression and Cushing's disease: Project for a volumetric study 71
Il disturbo bipolare 67
Multiple perforating lesions and chronic daily headache:a case report 67
Health-related quality of life in Italian patients with systemic lupus erythematosus 65
Neurotoxychological Monitoring of Interferon treatment in Viral Hepatitis: a Pilot Sudy 64
IFN treatment in viral Hepatitis really affect mood and cognition? Neuropsychological Changes and Electrophysiological correlates 63
Genome scan for schizophrenia/bipolar disorder supports a susceptibility locus in 15q26 62
Heart rate variability parallels changes in psychiatric scales in interferon-treated patients with chronic hepatitis. 59
Intellectual Impairment and cognitiver evoked potentials in myotonic dystrophy 59
The cognitive effects of long-term interferon treatment for chronic viral hepatitis 59
The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment. 57
Prefrontal dysfunction in cirrhotic patients without overt hepatic encephalopathy decteted by the Stroop Test 56
Neurobiologia dell'aggressività  55
Psychiatric effects of conventional interferon versus pegilated interferon in chronic hepatitis patients after two and six months of therapy 54
The neurosteroid modulation of normal and pathological anxiety in humans 53
Major depressive disorders and coronary artery disease: a review on common pathophysiological pathways 53
Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals 53
Genetic inheritance of schizophrenia and bipolar disorder in an italian population isolate 51
Neurophysiological bases of IFN toxicity in the treatment of viral hepatitis: Psychiatric, cognitive changes and long-term electrophysiological correlates. 50
CLINICAL OBSERVATIONS ON PANIC DISORDERS 49
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C 47
Basi neurologiche e aspetti clinici della depressione ricorrente 45
ESAMI BIOUMORALI E STRUMENTALI IN PSICHIATRIA 44
Il dolore interiore (o il dolore in psichiatria) 44
A naturalistic study comparing two initial duloxetine dosing strategies in a clinical "real world" setting 44
Capitolo 9: I Disturbi dell'Umore 41
Recurrent Major Depression and Nuclear Magnetic Resonance: A volumetric study, 41
Characterization of a 7% carbon dioxide (C02) inhalation paradigm to evoke anxiety symptoms in healthy subjects 41
Studio prospettico osservazionale sull'incidenza del disturbo depressivo in pazienti affetti da malattia coronarica acuta e valutazione del decorso del disturbo depressivo 41
La psicoeducazione nei disturbi bipolari 40
La qualità  della vita nel lupus eritematoso sistemico. 40
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS. 40
Uso della paroxetina nell'alopecia areata 39
Effetti neuropsichiatrici dell'uso dell'interferone nel trattamento delle epatiti virali 39
Neurotrofine e RMN Cerebrale nel Disturbo Depressivo Maggiore, 37
Carbamazepine: A bridge between epilepsy and psychiatric disorders. Premises 37
[Affective disorders in general hospitals: the organic affective syndrome]. 37
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C. 36
Carbamazepine. A bridge between epilepsy and psychiatric disorders 35
Potential relevance of Corticotropin Releasing Hormone to the therapeutic action of carbamazepine in major affective disorders 34
Vagus Nerve Stimulation in Treatment-Resistant Depression: A Case Series of Long-Term Follow-up 33
LA BUONA PRATICA PRESCRITTIVA IN PSICOFARMACOLOGIA 33
Effetti neuropsichiatrici della terapia con interferon: uno studio prospettico di confronto tra PEG-IFN ed IFN α 33
Stress-responsive neurohormonal systems and the symptom complex of affective illness. 33
Multiple cerebral perforating lesions and chronic daily headache: a case report 33
EFFECTS OF ANTIPSYCHOTIC TREATMENTS ON SERUM PROLACTINE LEVELS. A COMPARATIVE NATURALISTIC STUDY 33
Late-onset affective and psychotic disorders: The challenge of disentangling neurodegenerative diseases from primary psychiatric disorders 31
Plasma interleukin-beta and tumor necrosis factor concentrations in obsessive-compulsive disorders 30
[Schizophrenic and affective disorders in multiple sclerosis. Description of 2 clinical cases]. 29
HCV e depressione lieve o moderata 29
Preventing interferon-induced depression in a sample of 44 chronic hepatitis C patients with risk factor for depression 29
Effects of carbamazepine on the hypohtalamic-pituitary-adrenal axis: potential relevance of its mechanism of action 28
Dal blocco del sistema nervoso vegetativo all’ibernazione artificiale: primi risultati di un nuovo indirizzo di terapia psichiatrica. La storia padovana della cloropromazina 28
Life Charting dei disturbi affettivi ricorrenti: Una guida completa alla valutazione clinica di Leverich GS e Post RM 27
Psicosi organiche I: Le psicosi esogene acute o delirium 27
Totale 6.698
Categoria #
all - tutte 23.292
article - articoli 18.368
book - libri 413
conference - conferenze 0
curatela - curatele 320
other - altro 170
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.737
Totale 45.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020846 0 0 0 0 98 108 93 131 96 175 73 72
2020/2021852 31 72 32 99 49 97 33 72 138 51 108 70
2021/20221.182 13 225 110 119 21 91 54 121 37 12 123 256
2022/2023991 235 92 27 98 148 143 13 60 121 11 37 6
2023/2024435 22 69 62 36 19 30 16 20 19 12 60 70
2024/2025372 17 153 95 93 14 0 0 0 0 0 0 0
Totale 7.024